It remains unknown how the lungs of patients with PAH process carboxyhemoglobin (COHb) and methemoglobin (metHb); which are compounds potentially involved in the pathogenesis of the disease [3–6]. Here, HBG2 is linked to pulmonary arterial hypertension.